Researchers were able to generate fertilized northern white rhinoceros eggs, according to Mashable.
In PLOS this week: microRNA expression changes in hepatocellular carcinoma, real-time PCR-based approach for diagnosing schistosomiasis, and more.
The firm saw steady growth in its research reagents and screening businesses, and a 155 percent revenue increase in its bioproduction unit.
The study will evaluate how Prolaris impacts prostate cancer treatment decisions, and how those decisions impact costs within UK's National Health Service.
The European companies aim to link individuals who have used direct-to-consumer genetic tests with clinical trials and other research programs.
Based in Warsaw, Poland, the technology was inspired by "ultra-fast" PCR methods from the Wittwer group and Scope plans to launch tests for MRSA and C. diff.
Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.
The Radiance platform uses laser force cytology technology to measure optical and fluidic forces within a microfluidic channel for cellular analysis.
A study published this week describing the new approach shows higher resolution than an earlier method that 10x Genomics is commercializing.
The Hôpitaux Universitaires Genève is to use IBM's Watson for Genomics to help guide treatment in complex cancer cases, according to Labiotech.eu.
Retraction Watch reports that a paper was pulled because it refers to a gene that doesn't exist in mice.
Former Orig3n employees raise concerns about its testing at Bloomberg Businessweek.